PACB - Pacific Biosciences of California Non-GAAP EPS of -$0.26 beats by $0.05 revenue of $47.57M beats by $7.66M

2023-08-02 16:11:56 ET

• Pacific Biosciences of California press release ( NASDAQ: PACB ): Q2 Non-GAAP EPS of -$0.26 beats by $0.05 .
• Revenue of $47.57M (+34.0% Y/Y) beats by $7.66M .
• Recognized revenue on 47 sequencing systems in the second quarter, including 45 Revio systems and 2 Sequel IIe systems, compared to 36 Sequel II/IIe systems in the prior-year period.
• Instrument revenue of $29.9 million compared with $15.6 million in the prior-year period.
• Consumables revenue of $13.7 million compared with $14.6 million in the prior-year period.
• Service and other revenue of $3.9 million compared with $5.3 million in the prior-year period.

For further details see: